9 Meters Biopharma Inc.

NASDAQ: NMTR · Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM

9 Meters Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-42.02M -36.76M
Interest Income
501.23K 22.71K
Pretax Income
-43.77M -36.78M
Net Income
-45.52M -36.83M
Selling & General & Admin
11.01M 9.66M
Research & Development
31.01M 22M
Other Expenses
n/a 5.1B
Operating Expenses
42.02M 31.66M
Interest Expense
2.67M 47.19K
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
42.02M 31.66M
Income Tax Expense
1.75M 47.19K
Shares Outstanding (Basic)
12.96M 12.16M
Shares Outstanding (Diluted)
12.96M 12.16M
EPS (Basic)
-3.51 -3.03
EPS (Diluted)
-3.51 -3.03
EBITDA
-41.51M -31.63M
EBIT
-41.1M -41.81M
Depreciation & Amortization
509.75K 5.13M